14-3-3 protein in the cerebrospinal fluid of patients with acute transverse myelitis and multiple sclerosis
- 1 May 2002
- journal article
- Published by Springer Nature in Zeitschrift für Neurologie
- Vol. 249 (5) , 626-627
- https://doi.org/10.1007/s004150200074
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- 14-3-3 protein in the CSF as prognostic marker in early multiple sclerosisNeurology, 2001
- CSF detection of the 14-3-3 protein in unselected patients with dementiaNeurology, 2001
- Neurological disability correlates with spinal cord axonal loss and reduced N‐acetyl aspartate in chronic multiple sclerosis patientsAnnals of Neurology, 2000
- Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt–Jakob diseaseNeurology, 2000
- 14-3-3 Proteins: Structure, Function, and RegulationAnnual Review of Pharmacology and Toxicology, 2000
- 14-3-3 protein in the cerebrospinal fluid of patients with acute transverse myelitisThe Lancet, 2000
- Detection of 14-3-3 brain protein in the cerebrospinal fluid of patients with paraneoplastic neurological disordersAnnals of Neurology, 1999
- 14-3-3 protein, neuron-specific enolase, and S-100 protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.Dementia and Geriatric Cognitive Disorders, 1998
- Defining the clinical course of multiple sclerosisNeurology, 1996
- Rating neurologic impairment in multiple sclerosisNeurology, 1983